Drug intelligence / Profile preview

[18F]-D-AIP(FPPA)

Development stage
Preclinical
Lead developer
McGill University
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules, Peptides
Administration
Intravenous
01

Overview

[18F]-D-AIP(FPPA) is a first-in-class, small-molecule peptidomimetic positron emission tomography (PET) tracer designed for the selective imaging of soluble amyloid-beta (Aβ) oligomers [18F]-D-AIP(FPPA). Developed by researchers at McGill University, the tracer is derived from D-AIP (D-amino acid Aβ42 oligomer-interacting Peptide), an 8-amino acid peptide that specifically binds to and neutralizes toxic Aβ42 oligomers. By substituting the C-terminus of D-AIP with a fluorine-18 labeled phenylalanine mimic ([18F]-Fppa) using a novel radiolabeling methodology, the resulting tracer maintains high affinity for Aβ oligomers while minimizing plaque-related signals [18F]-D-AIP(FPPA). This allows for the visualization of Aβ aggregation in its earliest stages (*in statu nascendi*), potentially enabling early diagnosis of Alzheimer's disease and the evaluation of oligomer-specific therapeutics [18F]-D-AIP(FPPA).

Other names
18F-D-AIP(FPPA)[18F]-D-AIP(Fppa)[18F]D-AIP(FPPA)
02

Targets

Aβ (Amyloid-beta peptides and aggregates)

Beyond the preview

Go deeper on [18F]-D-AIP(FPPA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on [18F]-D-AIP(FPPA).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call